Industry Research Reports

Home > Reports > Chemical & Material > Global Indapamide API Market Research Report 2026

Global Indapamide API Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-04-18

Pages: 150 Pages

Report ld: 6502391

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Indapamide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Indapamide API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Indapamide API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Indapamide API. The Indapamide API market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Indapamide API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Indapamide API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Otto Brandes
Biotechnica Pharma Global
CHEMO
Hepartex
Octavius Pharma Pvt. Ltd
Torrent Pharmaceuticals Limited
PharmaZell
Recipharm AB
Bioindustria L.I.M. Spa
Ipca Laboratories
Laboratori Alchemia Srl
Supra Chemicals
Suzhou Lixin Pharmaceutical
Refarmed Chemicals
Osmopharm
Tianjin Pacific Chemical & Pharma
Guangzhou Tosun Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Indapamide API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Indapamide API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Indapamide API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Indapamide API Market Overview

1.1 Product Definition

1.2 Indapamide API by Type

1.2.1 Global Indapamide API Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Above 98 %

1.2.3 Above 99 %

1.3 Indapamide API by Application

1.3.1 Global Indapamide API Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Tablets

1.3.3 Others

1.4 Global Market Growth Prospects

1.4.1 Global Indapamide API Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Indapamide API Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Indapamide API Production Estimates and Forecasts (2021–2032)

1.4.4 Global Indapamide API Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Indapamide API Production Market Share by Manufacturers (2021–2026)

2.2 Global Indapamide API Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Indapamide API, Industry Ranking, 2024 vs 2025

2.4 Global Indapamide API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Indapamide API Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Indapamide API, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Indapamide API, Product Offerings and Applications

2.8 Global Key Manufacturers of Indapamide API, Date of Entry into the Industry

2.9 Indapamide API Market Competitive Situation and Trends

2.9.1 Indapamide API Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Indapamide API Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Indapamide API Production by Region

3.1 Global Indapamide API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Indapamide API Production Value by Region (2021–2032)

3.2.1 Global Indapamide API Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Indapamide API by Region (2027–2032)

3.3 Global Indapamide API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Indapamide API Production Volume by Region (2021–2032)

3.4.1 Global Indapamide API Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Indapamide API by Region (2027–2032)

3.5 Global Indapamide API Market Price Analysis by Region (2021–2032)

3.6 Global Indapamide API Production, Value, and Year-over-Year Growth

3.6.1 Europe Indapamide API Production Value Estimates and Forecasts (2021–2032)

3.6.2 China Indapamide API Production Value Estimates and Forecasts (2021–2032)

3.6.3 India Indapamide API Production Value Estimates and Forecasts (2021–2032)

3.6.4 Mid East & Africa Indapamide API Production Value Estimates and Forecasts (2021–2032)

4 Indapamide API Consumption by Region

4.1 Global Indapamide API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Indapamide API Consumption by Region (2021–2032)

4.2.1 Global Indapamide API Consumption by Region (2021–2026)

4.2.2 Global Indapamide API Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Indapamide API Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Indapamide API Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Indapamide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Indapamide API Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Indapamide API Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Indapamide API Production by Type (2021–2032)

5.1.1 Global Indapamide API Production by Type (2021–2026)

5.1.2 Global Indapamide API Production by Type (2027–2032)

5.1.3 Global Indapamide API Production Market Share by Type (2021–2032)

5.2 Global Indapamide API Production Value by Type (2021–2032)

5.2.1 Global Indapamide API Production Value by Type (2021–2026)

5.2.2 Global Indapamide API Production Value by Type (2027–2032)

5.2.3 Global Indapamide API Production Value Market Share by Type (2021–2032)

5.3 Global Indapamide API Price by Type (2021–2032)

6 Segment by Application

6.1 Global Indapamide API Production by Application (2021–2032)

6.1.1 Global Indapamide API Production by Application (2021–2026)

6.1.2 Global Indapamide API Production by Application (2027–2032)

6.1.3 Global Indapamide API Production Market Share by Application (2021–2032)

6.2 Global Indapamide API Production Value by Application (2021–2032)

6.2.1 Global Indapamide API Production Value by Application (2021–2026)

6.2.2 Global Indapamide API Production Value by Application (2027–2032)

6.2.3 Global Indapamide API Production Value Market Share by Application (2021–2032)

6.3 Global Indapamide API Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Otto Brandes

7.1.1 Otto Brandes Indapamide API Company Information

7.1.2 Otto Brandes Indapamide API Product Portfolio

7.1.3 Otto Brandes Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Otto Brandes Main Business and Markets Served

7.1.5 Otto Brandes Recent Developments/Updates

7.2 Biotechnica Pharma Global

7.2.1 Biotechnica Pharma Global Indapamide API Company Information

7.2.2 Biotechnica Pharma Global Indapamide API Product Portfolio

7.2.3 Biotechnica Pharma Global Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Biotechnica Pharma Global Main Business and Markets Served

7.2.5 Biotechnica Pharma Global Recent Developments/Updates

7.3 CHEMO

7.3.1 CHEMO Indapamide API Company Information

7.3.2 CHEMO Indapamide API Product Portfolio

7.3.3 CHEMO Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 CHEMO Main Business and Markets Served

7.3.5 CHEMO Recent Developments/Updates

7.4 Hepartex

7.4.1 Hepartex Indapamide API Company Information

7.4.2 Hepartex Indapamide API Product Portfolio

7.4.3 Hepartex Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Hepartex Main Business and Markets Served

7.4.5 Hepartex Recent Developments/Updates

7.5 Octavius Pharma Pvt. Ltd

7.5.1 Octavius Pharma Pvt. Ltd Indapamide API Company Information

7.5.2 Octavius Pharma Pvt. Ltd Indapamide API Product Portfolio

7.5.3 Octavius Pharma Pvt. Ltd Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Octavius Pharma Pvt. Ltd Main Business and Markets Served

7.5.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates

7.6 Torrent Pharmaceuticals Limited

7.6.1 Torrent Pharmaceuticals Limited Indapamide API Company Information

7.6.2 Torrent Pharmaceuticals Limited Indapamide API Product Portfolio

7.6.3 Torrent Pharmaceuticals Limited Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Torrent Pharmaceuticals Limited Main Business and Markets Served

7.6.5 Torrent Pharmaceuticals Limited Recent Developments/Updates

7.7 PharmaZell

7.7.1 PharmaZell Indapamide API Company Information

7.7.2 PharmaZell Indapamide API Product Portfolio

7.7.3 PharmaZell Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 PharmaZell Main Business and Markets Served

7.7.5 PharmaZell Recent Developments/Updates

7.8 Recipharm AB

7.8.1 Recipharm AB Indapamide API Company Information

7.8.2 Recipharm AB Indapamide API Product Portfolio

7.8.3 Recipharm AB Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Recipharm AB Main Business and Markets Served

7.8.5 Recipharm AB Recent Developments/Updates

7.9 Bioindustria L.I.M. Spa

7.9.1 Bioindustria L.I.M. Spa Indapamide API Company Information

7.9.2 Bioindustria L.I.M. Spa Indapamide API Product Portfolio

7.9.3 Bioindustria L.I.M. Spa Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Bioindustria L.I.M. Spa Main Business and Markets Served

7.9.5 Bioindustria L.I.M. Spa Recent Developments/Updates

7.10 Ipca Laboratories

7.10.1 Ipca Laboratories Indapamide API Company Information

7.10.2 Ipca Laboratories Indapamide API Product Portfolio

7.10.3 Ipca Laboratories Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Ipca Laboratories Main Business and Markets Served

7.10.5 Ipca Laboratories Recent Developments/Updates

7.11 Laboratori Alchemia Srl

7.11.1 Laboratori Alchemia Srl Indapamide API Company Information

7.11.2 Laboratori Alchemia Srl Indapamide API Product Portfolio

7.11.3 Laboratori Alchemia Srl Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 Laboratori Alchemia Srl Main Business and Markets Served

7.11.5 Laboratori Alchemia Srl Recent Developments/Updates

7.12 Supra Chemicals

7.12.1 Supra Chemicals Indapamide API Company Information

7.12.2 Supra Chemicals Indapamide API Product Portfolio

7.12.3 Supra Chemicals Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.12.4 Supra Chemicals Main Business and Markets Served

7.12.5 Supra Chemicals Recent Developments/Updates

7.13 Suzhou Lixin Pharmaceutical

7.13.1 Suzhou Lixin Pharmaceutical Indapamide API Company Information

7.13.2 Suzhou Lixin Pharmaceutical Indapamide API Product Portfolio

7.13.3 Suzhou Lixin Pharmaceutical Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.13.4 Suzhou Lixin Pharmaceutical Main Business and Markets Served

7.13.5 Suzhou Lixin Pharmaceutical Recent Developments/Updates

7.14 Refarmed Chemicals

7.14.1 Refarmed Chemicals Indapamide API Company Information

7.14.2 Refarmed Chemicals Indapamide API Product Portfolio

7.14.3 Refarmed Chemicals Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.14.4 Refarmed Chemicals Main Business and Markets Served

7.14.5 Refarmed Chemicals Recent Developments/Updates

7.15 Osmopharm

7.15.1 Osmopharm Indapamide API Company Information

7.15.2 Osmopharm Indapamide API Product Portfolio

7.15.3 Osmopharm Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.15.4 Osmopharm Main Business and Markets Served

7.15.5 Osmopharm Recent Developments/Updates

7.16 Tianjin Pacific Chemical & Pharma

7.16.1 Tianjin Pacific Chemical & Pharma Indapamide API Company Information

7.16.2 Tianjin Pacific Chemical & Pharma Indapamide API Product Portfolio

7.16.3 Tianjin Pacific Chemical & Pharma Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.16.4 Tianjin Pacific Chemical & Pharma Main Business and Markets Served

7.16.5 Tianjin Pacific Chemical & Pharma Recent Developments/Updates

7.17 Guangzhou Tosun Pharmaceutical

7.17.1 Guangzhou Tosun Pharmaceutical Indapamide API Company Information

7.17.2 Guangzhou Tosun Pharmaceutical Indapamide API Product Portfolio

7.17.3 Guangzhou Tosun Pharmaceutical Indapamide API Production, Value, Price, and Gross Margin (2021–2026)

7.17.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served

7.17.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Indapamide API Industry Chain Analysis

8.2 Indapamide API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Indapamide API Production Modes and Processes

8.4 Indapamide API Sales and Marketing

8.4.1 Indapamide API Sales Channels

8.4.2 Indapamide API Distributors

8.5 Indapamide API Customer Analysis

9 Indapamide API Market Dynamics

9.1 Indapamide API Industry Trends

9.2 Indapamide API Market Drivers

9.3 Indapamide API Market Challenges

9.4 Indapamide API Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Indapamide API Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Indapamide API Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Indapamide API Production Capacity (Kg) by Manufacturers in 2025

Table 4. Global Indapamide API Production by Manufacturers (Kg), 2021–2026

Table 5. Global Indapamide API Production Market Share by Manufacturers (2021–2026)

Table 6. Global Indapamide API Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Indapamide API Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Indapamide API, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Indapamide API Production Value, 2025

Table 10. Global Market Indapamide API Average Price by Manufacturers (US$/Kg), 2021–2026

Table 11. Global Key Manufacturers of Indapamide API, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Indapamide API, Product Offerings and Applications

Table 13. Global Key Manufacturers of Indapamide API, Date of Entry into the Industry

Table 14. Global Indapamide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Indapamide API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Indapamide API Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Indapamide API Production Value Market Share by Region (2021–2026)

Table 19. Global Indapamide API Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Indapamide API Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Indapamide API Production Comparison by Region: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Indapamide API Production (Kg) by Region (2021–2026)

Table 23. Global Indapamide API Production Market Share by Region (2021–2026)

Table 24. Global Indapamide API Production (Kg) Forecast by Region (2027–2032)

Table 25. Global Indapamide API Production Market Share Forecast by Region (2027–2032)

Table 26. Global Indapamide API Market Average Price (US$/Kg) by Region (2021–2026)

Table 27. Global Indapamide API Market Average Price (US$/Kg) by Region (2027–2032)

Table 28. Global Indapamide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Kg)

Table 29. Global Indapamide API Consumption by Region (Kg), 2021–2026

Table 30. Global Indapamide API Consumption Market Share by Region (2021–2026)

Table 31. Global Indapamide API Forecasted Consumption by Region (Kg), 2027–2032

Table 32. Global Indapamide API Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Kg)

Table 34. North America Indapamide API Consumption by Country (Kg), 2021–2026

Table 35. North America Indapamide API Consumption by Country (Kg), 2027–2032

Table 36. Europe Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Kg)

Table 37. Europe Indapamide API Consumption by Country (Kg), 2021–2026

Table 38. Europe Indapamide API Consumption by Country (Kg), 2027–2032

Table 39. Asia Pacific Indapamide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Kg)

Table 40. Asia Pacific Indapamide API Consumption by Region (Kg), 2021–2026

Table 41. Asia Pacific Indapamide API Consumption by Region (Kg), 2027–2032

Table 42. Latin America, Middle East & Africa Indapamide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Kg)

Table 43. Latin America, Middle East & Africa Indapamide API Consumption by Country (Kg), 2021–2026

Table 44. Latin America, Middle East & Africa Indapamide API Consumption by Country (Kg), 2027–2032

Table 45. Global Indapamide API Production (Kg) by Type (2021–2026)

Table 46. Global Indapamide API Production (Kg) by Type (2027–2032)

Table 47. Global Indapamide API Production Market Share by Type (2021–2026)

Table 48. Global Indapamide API Production Market Share by Type (2027–2032)

Table 49. Global Indapamide API Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Indapamide API Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Indapamide API Production Value Market Share by Type (2021–2026)

Table 52. Global Indapamide API Production Value Market Share by Type (2027–2032)

Table 53. Global Indapamide API Price (US$/Kg) by Type (2021–2026)

Table 54. Global Indapamide API Price (US$/Kg) by Type (2027–2032)

Table 55. Global Indapamide API Production (Kg) by Application (2021–2026)

Table 56. Global Indapamide API Production (Kg) by Application (2027–2032)

Table 57. Global Indapamide API Production Market Share by Application (2021–2026)

Table 58. Global Indapamide API Production Market Share by Application (2027–2032)

Table 59. Global Indapamide API Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Indapamide API Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Indapamide API Production Value Market Share by Application (2021–2026)

Table 62. Global Indapamide API Production Value Market Share by Application (2027–2032)

Table 63. Global Indapamide API Price (US$/Kg) by Application (2021–2026)

Table 64. Global Indapamide API Price (US$/Kg) by Application (2027–2032)

Table 65. Otto Brandes Indapamide API Company Information

Table 66. Otto Brandes Indapamide API Specification and Application

Table 67. Otto Brandes Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 68. Otto Brandes Main Business and Markets Served

Table 69. Otto Brandes Recent Developments/Updates

Table 70. Biotechnica Pharma Global Indapamide API Company Information

Table 71. Biotechnica Pharma Global Indapamide API Specification and Application

Table 72. Biotechnica Pharma Global Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 73. Biotechnica Pharma Global Main Business and Markets Served

Table 74. Biotechnica Pharma Global Recent Developments/Updates

Table 75. CHEMO Indapamide API Company Information

Table 76. CHEMO Indapamide API Specification and Application

Table 77. CHEMO Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 78. CHEMO Main Business and Markets Served

Table 79. CHEMO Recent Developments/Updates

Table 80. Hepartex Indapamide API Company Information

Table 81. Hepartex Indapamide API Specification and Application

Table 82. Hepartex Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 83. Hepartex Main Business and Markets Served

Table 84. Hepartex Recent Developments/Updates

Table 85. Octavius Pharma Pvt. Ltd Indapamide API Company Information

Table 86. Octavius Pharma Pvt. Ltd Indapamide API Specification and Application

Table 87. Octavius Pharma Pvt. Ltd Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 88. Octavius Pharma Pvt. Ltd Main Business and Markets Served

Table 89. Octavius Pharma Pvt. Ltd Recent Developments/Updates

Table 90. Torrent Pharmaceuticals Limited Indapamide API Company Information

Table 91. Torrent Pharmaceuticals Limited Indapamide API Specification and Application

Table 92. Torrent Pharmaceuticals Limited Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 93. Torrent Pharmaceuticals Limited Main Business and Markets Served

Table 94. Torrent Pharmaceuticals Limited Recent Developments/Updates

Table 95. PharmaZell Indapamide API Company Information

Table 96. PharmaZell Indapamide API Specification and Application

Table 97. PharmaZell Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 98. PharmaZell Main Business and Markets Served

Table 99. PharmaZell Recent Developments/Updates

Table 100. Recipharm AB Indapamide API Company Information

Table 101. Recipharm AB Indapamide API Specification and Application

Table 102. Recipharm AB Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 103. Recipharm AB Main Business and Markets Served

Table 104. Recipharm AB Recent Developments/Updates

Table 105. Bioindustria L.I.M. Spa Indapamide API Company Information

Table 106. Bioindustria L.I.M. Spa Indapamide API Specification and Application

Table 107. Bioindustria L.I.M. Spa Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 108. Bioindustria L.I.M. Spa Main Business and Markets Served

Table 109. Bioindustria L.I.M. Spa Recent Developments/Updates

Table 110. Ipca Laboratories Indapamide API Company Information

Table 111. Ipca Laboratories Indapamide API Specification and Application

Table 112. Ipca Laboratories Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 113. Ipca Laboratories Main Business and Markets Served

Table 114. Ipca Laboratories Recent Developments/Updates

Table 115. Laboratori Alchemia Srl Indapamide API Company Information

Table 116. Laboratori Alchemia Srl Indapamide API Specification and Application

Table 117. Laboratori Alchemia Srl Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 118. Laboratori Alchemia Srl Main Business and Markets Served

Table 119. Laboratori Alchemia Srl Recent Developments/Updates

Table 120. Supra Chemicals Indapamide API Company Information

Table 121. Supra Chemicals Indapamide API Specification and Application

Table 122. Supra Chemicals Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 123. Supra Chemicals Main Business and Markets Served

Table 124. Supra Chemicals Recent Developments/Updates

Table 125. Suzhou Lixin Pharmaceutical Indapamide API Company Information

Table 126. Suzhou Lixin Pharmaceutical Indapamide API Specification and Application

Table 127. Suzhou Lixin Pharmaceutical Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 128. Suzhou Lixin Pharmaceutical Main Business and Markets Served

Table 129. Suzhou Lixin Pharmaceutical Recent Developments/Updates

Table 130. Refarmed Chemicals Indapamide API Company Information

Table 131. Refarmed Chemicals Indapamide API Specification and Application

Table 132. Refarmed Chemicals Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 133. Refarmed Chemicals Main Business and Markets Served

Table 134. Refarmed Chemicals Recent Developments/Updates

Table 135. Osmopharm Indapamide API Company Information

Table 136. Osmopharm Indapamide API Specification and Application

Table 137. Osmopharm Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 138. Osmopharm Main Business and Markets Served

Table 139. Osmopharm Recent Developments/Updates

Table 140. Tianjin Pacific Chemical & Pharma Indapamide API Company Information

Table 141. Tianjin Pacific Chemical & Pharma Indapamide API Specification and Application

Table 142. Tianjin Pacific Chemical & Pharma Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 143. Tianjin Pacific Chemical & Pharma Main Business and Markets Served

Table 144. Tianjin Pacific Chemical & Pharma Recent Developments/Updates

Table 145. Guangzhou Tosun Pharmaceutical Indapamide API Company Information

Table 146. Guangzhou Tosun Pharmaceutical Indapamide API Specification and Application

Table 147. Guangzhou Tosun Pharmaceutical Indapamide API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 148. Guangzhou Tosun Pharmaceutical Main Business and Markets Served

Table 149. Guangzhou Tosun Pharmaceutical Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Indapamide API Distributors List

Table 153. Indapamide API Customers List

Table 154. Indapamide API Market Trends

Table 155. Indapamide API Market Drivers

Table 156. Indapamide API Market Challenges

Table 157. Indapamide API Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Indapamide API

Figure 2. Global Indapamide API Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Indapamide API Market Share by Type: 2025 vs 2032

Figure 4. Above 98 % Product Picture

Figure 5. Above 99 % Product Picture

Figure 6. Global Indapamide API Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Indapamide API Market Share by Application: 2025 vs 2032

Figure 8. Tablets

Figure 9. Others

Figure 10. Global Indapamide API Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Indapamide API Production Value (US$ Million), 2021–2032

Figure 12. Global Indapamide API Production Capacity (Kg), 2021–2032

Figure 13. Global Indapamide API Production (Kg), 2021–2032

Figure 14. Global Indapamide API Average Price (US$/Kg), 2021–2032

Figure 15. Indapamide API Report Years Considered

Figure 16. Indapamide API Production Share by Manufacturers in 2025

Figure 17. Global Indapamide API Production Value Share by Manufacturers (2025)

Figure 18. Indapamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Top 5 and Top 10 Global Players: Market Share by Indapamide API Revenue in 2025

Figure 20. Global Indapamide API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 21. Global Indapamide API Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 22. Global Indapamide API Production Comparison by Region: 2021 vs 2025 vs 2032 (Kg)

Figure 23. Global Indapamide API Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 24. Europe Indapamide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 25. China Indapamide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. India Indapamide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Mid East & Africa Indapamide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Global Indapamide API Consumption by Region: 2021 vs 2025 vs 2032 (Kg)

Figure 29. Global Indapamide API Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 30. North America Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 31. North America Indapamide API Consumption Market Share by Country (2021–2032)

Figure 32. U.S. Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 33. Canada Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 34. Europe Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 35. Europe Indapamide API Consumption Market Share by Country (2021–2032)

Figure 36. Germany Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 37. France Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 38. U.K. Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 39. Italy Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 40. Russia Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 41. Asia Pacific Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 42. Asia Pacific Indapamide API Consumption Market Share by Region (2021–2032)

Figure 43. China Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 44. Japan Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 45. South Korea Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 46. China Taiwan Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 47. Southeast Asia Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 48. India Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 49. Latin America, Middle East & Africa Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 50. Latin America, Middle East & Africa Indapamide API Consumption Market Share by Country (2021–2032)

Figure 51. Mexico Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 52. Brazil Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 53. Turkey Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 54. GCC Countries Indapamide API Consumption and Growth Rate (Kg), 2021–2032

Figure 55. Global Production Market Share of Indapamide API by Type (2021–2032)

Figure 56. Global Production Value Market Share of Indapamide API by Type (2021–2032)

Figure 57. Global Indapamide API Price (US$/Kg) by Type (2021–2032)

Figure 58. Global Production Market Share of Indapamide API by Application (2021–2032)

Figure 59. Global Production Value Market Share of Indapamide API by Application (2021–2032)

Figure 60. Global Indapamide API Price (US$/Kg) by Application (2021–2032)

Figure 61. Indapamide API Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Indapamide API market? zhanKai

The top companies in the global Indapamide API market are Otto Brandes、Biotechnica Pharma Global、CHEMO.

Related Reports

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Indapamide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 104
USD 4250.00
(Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 174
USD 4900.00
(Single User License)
Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Indapamide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 145
USD 3950.00
(Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published Date: 2024-02-07
Pages: 113
USD 2900.00
(Single User License)

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 153
USD 3950.00 (Single User License)
Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Indapamide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 104
USD 4250.00 (Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 174
USD 4900.00 (Single User License)
Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Indapamide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 145
USD 3950.00 (Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published: 2024-02-07
Pages: 113
USD 2900.00 (Single User License)